We are live on
!
Find out more
RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$419M
1-Year Est. Return
31.15%
This Fund
S&P 500
This Quarter
Est. Return
+13.98%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
–
AUM
$339M
AUM Growth
+$81.7M
(+32%)
Cap. Flow
+$34.2M
Cap. Flow
% of AUM
10.07%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
264
New
45
Increased
111
Reduced
78
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.74M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.76M |
| 3 |
iShares S&P 500 Growth ETF
IVW
|
+$2.39M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.84M |
| 5 |
Costco
COST
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADMA Biologics
ADMA
|
+$1.36M |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$694K |
| 3 |
Krystal Biotech
KRYS
|
+$654K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$549K |
| 5 |
3M
MMM
|
+$519K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Industrials | 8.26% |
| 3 | Financials | 7.38% |
| 4 | Consumer Discretionary | 7.26% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Emcor
EME
$36B
| – | – |
-889
| Closed | -$347K |
|
252
Eastman Chemical
EMN
$8.55B
| – | – |
-2,864
| Closed | -$223K |
|
253
SPDR Gold MiniShares Trust
GLDM
$29.9B
| – | – |
-7,506
| Closed | -$480K |
|
254
Halozyme
HALO
$11.6B
| – | – |
-6,751
| Closed | -$414K |
|
|
255
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.75B
| – | – |
-20,179
| Closed | -$694K |
|
256
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.36B
| – | – |
-8,226
| Closed | -$200K |
|
|
IBTF
257
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
| – | – |
-8,740
| Closed | -$204K |
|
|
258
Krystal Biotech
KRYS
$9.68B
| – | – |
-3,867
| Closed | -$654K |
|
259
Lockheed Martin
LMT
$138B
| – | – |
-429
| Closed | -$201K |
|
260
lululemon athletica
LULU
$14.3B
| – | – |
-849
| Closed | -$217K |
|
|
261
3M
MMM
$94.4B
| – | – |
-3,838
| Closed | -$519K |
|
262
Philip Morris
PM
$290B
| – | – |
-2,035
| Closed | -$326K |
|
263
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| – | – |
-5,627
| Closed | -$465K |
|
264
UnitedHealth
UNH
$361B
| – | – |
-541
| Closed | -$316K |
|
Similar funds
MMG
DBRC
CMHI
PIMC
VIS
AI
TI
MCM
Roman Butler Fullerton & Co's Q2 2025 Portfolio in Review
As of Q2 2025, Roman Butler Fullerton & Co held 264 positions worth $339M, up 32% from $258M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Roman Butler Fullerton & Co deployed $34.2M of net new capital in Q2 2025, opening 45 new positions and adding to 111 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 32,284 shares worth $2.93M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Schwab US Dividend Equity ETF, an estimated $549K trimmed.
- Roman Butler Fullerton & Co's largest Q2 2025 buy was iShares MSCI EAFE ETF: 32,284 shares worth $2.93M.
- Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $4.74M increase.
- Roman Butler Fullerton & Co's biggest Q2 2025 reduction was Schwab US Dividend Equity ETF, cutting an estimated $549K.
- Roman Butler Fullerton & Co fully exited ADMA Biologics in Q2 2025, selling an estimated $1.36M.
- Roman Butler Fullerton & Co's ten largest holdings make up 31% of its $339M portfolio in Q2 2025.
- Roman Butler Fullerton & Co opened 45 new positions and closed 22 in Q2 2025.
- Roman Butler Fullerton & Co's portfolio value rose 32% quarter-over-quarter to $339M.
Based on Roman Butler Fullerton & Co's 13F filing for Q2 2025, filed 30 Jul 2025.